Le guselkumab, inhibiteur de l’interleukine 23, efficace dans le traitement du psoriasis

Colmant, Caroline;Ghislain, Pierre-Dominique
(2018) Louvain médical — Vol. 137, n° 8, p. 441-444 (2018)

Files

2018_Colmant_LM_441-444.pdf
  • Restricted Access
  • Adobe PDF
  • 75 KB
Request a copy

Details

Authors
Abstract
(en) [Guselkumab, an effective interleukin-23 inhibitor in the treatment of psoriasis] Guselkumab is a selective interleukin-23 inhibitor that has been marketed and reimbursed since a few months in Belgium. We conducted a literature review in order to assess the efficacy and safety of guselkumab.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Colmant, C., & Ghislain, P.-D. (2018). Le guselkumab, inhibiteur de l’interleukine 23, efficace dans le traitement du psoriasis. Louvain médical, 137(8), 441-444. https://hdl.handle.net/2078.5/119833 (Original work published 2018)